HomeNBRVF • OTCMKTS
add
Nabriva Therapeutics PLC - ADR
Previous close
$0.00010
Day range
$0.00010 - $0.00010
Market cap
323.08 USD
Avg Volume
279.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Yahoo
1 hour ago
What Standard Lithium (TSXV:SLI)'s US$130 Million Equity Raise Means For Shareholders
4.20%
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 36.94M | 27.82% |
Operating expense | 45.26M | -12.36% |
Net income | -57.18M | -15.64% |
Net profit margin | -154.83 | 9.53% |
Earnings per share | — | — |
EBITDA | -55.27M | -14.74% |
Effective tax rate | -2.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.41M | -73.96% |
Total assets | 31.76M | -60.74% |
Total liabilities | 28.47M | 3.31% |
Total equity | 3.29M | — |
Shares outstanding | 3.20M | — |
Price to book | 0.00 | — |
Return on assets | -61.56% | — |
Return on capital | -99.24% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -57.18M | -15.64% |
Cash from operations | -36.71M | 38.36% |
Cash from investing | -263.00K | -224.69% |
Cash from financing | 1.85M | -97.21% |
Net change in cash | -35.30M | -665.29% |
Free cash flow | -15.05M | 63.87% |
About
Founded
2005
Website
Employees
39
